Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014 (2014), Article ID 890438, 5 pages
http://dx.doi.org/10.1155/2014/890438
Case Report

Clinical Lessons to Be Learned from Patients Developing Chronic Myeloid Leukemia While on Immunosuppressive Therapy after Solid Organ Transplantation: Yet Another Case after Orthotopic Heart Transplantation

1Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Universitätsmedizin Berlin, Campus Mitte Charité, Schumannstraße 20/21, 10117 Berlin, Germany
2Deutsches Herzzentrum Berlin, Abteilung für Herz-, Thorax- und Gefäßchirurgie, Augustenburger Platz 1, 13353 Berlin, Germany
3Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Universitätsmedizin Berlin, Campus Virchow Charité, Augustenburger Platz 1, 13353 Berlin, Germany

Received 31 August 2014; Revised 23 October 2014; Accepted 24 October 2014; Published 16 November 2014

Academic Editor: Kazunori Nakase

Copyright © 2014 Christian Oberender et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Zimmermann and R. U. Trappe, “EBV and posttransplantation lymphoproliferative disease: what to do?” Hematology, vol. 2013, no. 1, pp. 95–102, 2013. View at Publisher · View at Google Scholar
  2. D. Ondruš, V. Pribylincová, J. Breza et al., “The incidence of tumours in renal transplant recipients with long-term immunosuppressive therapy,” International Urology and Nephrology, vol. 31, no. 4, pp. 417–422, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. L. M. Morton, T. M. Gibson, C. A. Clarke et al., “Risk of myeloid neoplasms after solid organ transplantation,” Leukemia, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Battin, J. P. Hehunstre, N. B. Bui, J. Auzerie, and M. Colle, “Chronic myeloid leukaemia after immunosuppressive treatment for chronic nephropathy,” La Nouvelle Presse Médicale, vol. 5, p. 2632, 1976. View at Google Scholar
  5. K. R. Adler, N. Lempert, and W. B. Scharfman, “Chronic granulocytic leukemia following successful renal transplantation,” Cancer, vol. 41, no. 6, pp. 2206–2208, 1978. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Lubynski, A. M. Meyers, P. B. Disler, A. P. MacPhail, J. A. Myburgh, and J. Katz, “Chronic granulocytic leukemia in a patient with a renal allograft,” Archives of Internal Medicine, vol. 138, no. 9, pp. 1429–1430, 1978. View at Publisher · View at Google Scholar · View at Scopus
  7. J. M. V. Mooy, J. C. W. Hagenouw-Taal, L. D. F. Lameijer, and J. M. Van Turnhout, “Chronic granulocytic leukemia in a renal transplant recipient,” Cancer, vol. 41, no. 1, pp. 7–9, 1978. View at Google Scholar · View at Scopus
  8. R. Hilario, T. Padre-Mendoza, and M. M. Albala, “Chronic granulocytic leukemia and carcinoma of the cervix in situ following renal transplantation,” The American Journal of the Medical Sciences, vol. 280, no. 2, pp. 115–118, 1980. View at Publisher · View at Google Scholar · View at Scopus
  9. K. A. Kirchner, J. C. Files, R. Didlake, S. Raju, and R. P. Krueger, “Chronic granulocytic leukemia after renal transplantation,” Archives of Internal Medicine, vol. 143, no. 10, pp. 1984–1987, 1983. View at Publisher · View at Google Scholar · View at Scopus
  10. W. H. Frist and V. J. Biggs, “Chronic myelogenous leukemia after lymphoid irradiation and heart transplantation,” Annals of Thoracic Surgery, vol. 57, no. 1, pp. 214–216, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Sanz, F. Cervantes, J. Esteve et al., “Chronic myeloid leukaemia after renal transplantation: report of a new case and review of the bibliography,” Sangre, vol. 41, no. 5, pp. 391–393, 1996. View at Google Scholar · View at Scopus
  12. A. M. Stein, R. Anthone, S. Anthone, M. J. Marinello, C. M. Elwood, and R. M. Bannerman, “Chronic myelocytic leukemia in a young renal allografted patient,” Transplantation, vol. 26, no. 4, pp. 271–273, 1978. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Mignozzi and S. Picca, “Chronic myelogenous leukemia following kidney transplantation in a pediatric patient,” Pediatric Nephrology, vol. 16, no. 11, pp. 852–853, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. M. D. Pescovitz, N. A. Heerema, R. M. Jindal, M. L. Milgrom, S. B. Leapman, and R. S. Filo, “The natural history of chronic myelogenous leukemia in a renal transplant recipient,” Transplantation, vol. 61, no. 2, pp. 328–331, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Penn, “De novo malignances in pediatric organ transplant recipients,” Pediatric Transplantation, vol. 2, no. 1, pp. 56–63, 1998. View at Google Scholar · View at Scopus
  16. L. A. F. Pelloso, M. G. Vaz De Campos, M. Nascimento, M. R. R. Silva, J. O. M. Pestana, and M. D. L. L. F. Chauffaille, “Chronic myeloid leukemia following kidney transplantation,” Leukemia Research, vol. 29, no. 3, pp. 353–355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Koca, D. Cetiner, H. Goker et al., “Complete cytogenietic remission with imatinib mesylate treatment in chronic myelogenous leukemia (CML) developed after renal transplantation,” Clinical Nephrology, vol. 64, no. 4, pp. 324–326, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Concejero, C.-L. Chen, C.-C. Wang et al., “Chronic myeloid leukemia after living donor liver transplantation,” Transplantation, vol. 83, no. 11, pp. 1521–1522, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Thierry, B. Dreyfus, F. Bridoux et al., “Long-term molecular efficacy and safety of imatinib in a patient with chronic myeloid leukaemia after renal transplantation,” Nephrology Dialysis Transplantation, vol. 22, no. 6, pp. 1791–1792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Fontana, P. Dudkiewicz, L. L. Horstman, A. G. Tzakis, and Y. S. Ahn, “A typical chronic myeloid leukemia following organ transplants,” Clinical Transplantation, vol. 22, no. 2, pp. 258–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Le Coutre, P. Reinke, R. Neuhaus et al., “BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipients,” European Journal of Haematology, vol. 84, no. 1, pp. 26–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Castillo-Rama, C. Grande, P. Martinez-Sánchez et al., “Remisión molecular de una leucemia mieloide crónica en un paciente con Segundo trasplante renal y hepatitis,” Nefrologia, vol. 6, pp. 604–607, 2009. View at Google Scholar
  23. H. Sayar, A. A. Sharfuddin, T. E. Taber, and R. Mehta, “Chronic myeloid leukemia within a year of kidney transplant with elevated alkaline phosphatase correlated with imatinib therapy,” Experimental and Clinical Transplantation, vol. 9, no. 5, pp. 336–339, 2011. View at Google Scholar · View at Scopus
  24. M. M. Sbenghe, A. D. Florea, P. Mather, and E. Gitelson, “Chronic myeloid leukemia following heart transplantation and immunosuppression with tacrolimus,” Clinical Advances in Hematology and Oncology, vol. 9, no. 8, pp. 623–627, 2011. View at Google Scholar · View at Scopus
  25. A. E. Oskuei, K. Makhdoomi, S. Abkhiz, S. Vossoghian, and M. Farrokhpour, “Successful treatment of chronic myelogenic leukemia (CML) with Imatinib after renal transplantation,” Archives of Iranian Medicine, vol. 17, no. 5, pp. 388–390, 2014. View at Google Scholar · View at Scopus
  26. A. Dhanarajan, J. W. Hsu, P. le Coutre, J. R. Wingard, M. Chang, and M. Norkin, “Elevated incidence of chronic myeloid leukaemia in immunosuppressed solid organ transplant recipients,” British Journal of Haematology, vol. 166, no. 4, pp. 619–621, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. N. M. Menon, E. Katsanis, Z. Khalpey, and P. Whitlow, “Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy,” Pediatric Blood – Cancer, 2014. View at Publisher · View at Google Scholar
  28. S. Faderl, M. Talpaz, Z. Estrov, S. O'Brien, R. Kurzrock, and H. M. Kantarjian, “The biology of chronic myeloid leukemia,” The New England Journal of Medicine, vol. 341, no. 3, pp. 164–172, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Baccarani, M. W. Deininger, G. Rosti et al., “European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013,” Blood, vol. 122, no. 6, pp. 872–884, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Bose, M. Deininger, J. Gora-Tybor, J. M. Goldman, and J. V. Melo, “The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease,” Blood, vol. 92, no. 9, pp. 3362–3367, 1998. View at Google Scholar · View at Scopus
  31. C. Biernaux, M. Loos, A. Sels, G. Huez, and P. Stryckmans, “Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals,” Blood, vol. 86, no. 8, pp. 3118–3122, 1995. View at Google Scholar · View at Scopus
  32. K. J. Aichberger, S. Herndlhofer, G.-H. Schernthaner et al., “Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML,” American Journal of Hematology, vol. 86, no. 7, pp. 533–539, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Montani, E. Bergot, S. Günther et al., “Pulmonary arterial hypertension in patients treated by dasatinib,” Circulation, vol. 125, no. 17, pp. 2128–2137, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. P. O'Donovan, C. M. Perrett, X. Zhang et al., “Medicine: Azathioprine and UVA light generate mutagenic oxidative DNA damage,” Science, vol. 309, no. 5742, pp. 1871–1874, 2005. View at Publisher · View at Google Scholar · View at Scopus